Director, Medical Science Liaison

Company introduction

Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care.

The Company is headquartered in London, UK, with a U.S. office in New Jersey. We believe mental health patients deserve the possibility of a better future. Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress disorder (PTSD). COMP360 is a potentially first-in-class treatment and has Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA), as well as Innovative Licensing and Access Pathway (ILAP) designation in the UK for TRD.

We are leading the world's largest classic psychedelic clinical program in TRD, and building upon that robust foundation, we are executing a late-stage trial evaluating COMP360 for PTSD, another condition with high unmet need. Our goal is to advance treatments that move the field of psychiatry towards treatment options that offer rapid onset and sustained durability with infrequent dosing. - Compass Pathways

Job overview

The Director of Medical Science Liaison (Western US) at Compass Pathways will lead and develop a high-performing field medical team focused on impactful scientific engagement within the neuroscience and mental health community. This role is responsible for translating Compass's medical strategy into effective field activities, overseeing MSL operations across a defined region, and ensuring consistent, high-quality scientific exchange with external stakeholders.

The Director will drive execution of the national medical affairs plan, coach and mentor MSLs to enhance scientific credibility and performance, and partner closely with cross-functional teams to ensure that field insights help inform medical strategy, clinical development, and educational initi